Sex: M
Vaccine: COVID19, COVID19
Symptoms: Urticaria
Clinical narrative: Initially got some kind of covid in the fall and triggered.; Initially got some kind of covid in the fall and triggered.; anaphylactic; rash; shingles/Eczema blister like shingles; eczema/Eczema blister like shingles; Started affecting his one eye; Eczema blister like shingles; looked like hives; itches; spot by nose and eyebrow; The initial case was missing the following minimum criteria: unidentifiable patient. Upon receipt of follow-up information on 10Jan2022, this case now contains all required information to be considered valid.  This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant) all with onset 2021, outcome "not recovered" and all described as "Initially got some kind of covid in the fall and triggered."; ANAPHYLACTIC REACTION (medically significant) with onset 2021, outcome "not recovered", described as "anaphylactic"; RASH (non-serious) with onset 2021, outcome "not recovered", described as "rash"; HERPES ZOSTER (non-serious) with onset 2021, outcome "not recovered", described as "shingles/Eczema blister like shingles"; ECZEMA (non-serious) with onset 2021, outcome "not recovered", described as "eczema/Eczema blister like shingles"; OCULAR DISCOMFORT (non-serious) with onset 2021, outcome "not recovered", described as "Started affecting his one eye"; BLISTER (non-serious) with onset 2021, outcome "not recovered", described as "Eczema blister like shingles"; URTICARIA (non-serious) with onset 2021, outcome "not recovered", described as "looked like hives"; PRURITUS (non-serious) with onset 2021, outcome "not recovered", described as "itches"; MACULE (non-serious) with onset 2021, outcome "not recovered", described as "spot by nose and eyebrow". The event "rash" was evaluated at the physician office visit. The events "shingles/eczema blister like shingles", "eczema/eczema blister like shingles" and "eczema blister like shingles" were evaluated at the physician office visit and emergency room visit. The event "started affecting his one eye" was evaluated at the emergency room visit. Therapeutic measures were taken as a result of herpes zoster, eczema, blister, pruritus. The report was not related to a study or programme. This had been going on 3 or 4 months at the time of reporting. About two months actually, the patient went to the emergency room (ER) type place. Healthcare Professional (HCP) thought eczema blister like shingles and the patient took gabapentin, diphenhydramine hydrochloride (BENADRYL) for controlling it and had some eczema. The patient's one eye started being affected. Initially the patient got some kind of covid in the fall and triggered. The patient would receive shingles shot. This checked every box in the books for shingles. Every time the patient went to the doctor rash under control. The patient would describe it as anaphylactic. It looked like hives. diphenhydramine hydrochloride did help with the itches. Generally you got that as soon as they got the shot.The patient could not believe that it was eczema. The patient had a spot by nose and eyebrow. It did not seem like eczema. The patient had got medicare and shouldn't have any trouble. It may be gone or it may be worse. If it happened to die off, the patient was going to run down and get the shingles vaccine. The patient was putting off the booster.   The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200055776 Same patient, different dose and events